Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial. (otvara novi prozor)

Abdel-Aleem H, Alhusaini TK, Abdel-Aleem MA, Menoufy M, Gülmezoglu AM.

Izvor‎: J Matern Fetal Neonatal Med 2013;26(17):1705-9.

Indeks‎: PubMed 23574458

https://www.ncbi.nlm.nih.gov/pubmed/23574458 (otvara novi prozor)

Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients. (otvara novi prozor)

Gayet-Ageron A, Prieto-Merino D, Ker K, Shakur H, Ageron FX, Roberts I; Antifibrinolytic Trials Collaboration

Izvor‎: Lancet 2018;391(10116):125-32.

Indeks‎: PubMed 29126600

DOI‎: 10.1016/S0140-6736(17)32455-8

https://www.ncbi.nlm.nih.gov/pubmed/29126600 (otvara novi prozor)

Can intravenous injection of tranexamic acid be used in routine practice with active management of the third stage of labor in vaginal delivery? A randomized controlled study. (otvara novi prozor)

Gungorduk K, Asıcıoğlu O, Yıldırım G, Ark C, Tekirdağ Aİ, Besımoglu B.

Izvor‎: Am J Perinatol 2013;30(5):407-13.

Indeks‎: PubMed 23023559

DOI‎: 10.1055/s-0032-1326986

https://www.ncbi.nlm.nih.gov/pubmed/23023559 (otvara novi prozor)

Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study. (otvara novi prozor)

Gungorduk K, Yıldırım G, Asıcıoğlu O, Gungorduk OC, Sudolmus S, Ark C.

Izvor‎: Am J Perinatol 2011;28(3):233-40.

Indeks‎: PubMed 20979013

https://www.ncbi.nlm.nih.gov/pubmed/20979013 (otvara novi prozor)

Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. (otvara novi prozor)

Shakur S, Roberts I, Fawole B, Chaudhri R, El-Sheikh M, et al.; WOMAN Trial Collaborators

Izvor‎: Lancet 2017;389(10084):2105-16.

Indeks‎: PubMed 28456509

DOI‎: 10.1016/S0140-6736(17)30638-4

https://www.ncbi.nlm.nih.gov/pubmed/28456509 (otvara novi prozor)

Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials. (otvara novi prozor)

Simonazzi G, Bisulli M, Saccone G, Moro E, Marshall A, Berghella V.

Izvor‎: Acta Obstet Gynecol Scand 2016;95(1):28-37.

Indeks‎: PubMed 26698831

DOI‎: 10.1111/aogs.12798

https://www.ncbi.nlm.nih.gov/pubmed/26698831 (otvara novi prozor)

Randomized controlled trial of tranexamic acid among parturients at increased risk for postpartum hemorrhage undergoing cesarean delivery. (otvara novi prozor)

Sujata N, Tobin R, Kaur R, Aneja A, Khanna M, Hanjoora VM.

Izvor‎: Int J Gynaecol Obstet 2016;133(3):312-5.

Indeks‎: PubMed 26952346

DOI‎: 10.1016/j.ijgo.2015.09.032

https://www.ncbi.nlm.nih.gov/pubmed/26952346 (otvara novi prozor)

Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004. (otvara novi prozor)

Alfirevic Z, Elbourne D, Pavord S, Bolte A, Van Geijn H, Mercier F, Ahonen J, Bremme K, Bødker B, Magnúsdóttir EM, Salvesen K, Prendiville W, Truesdale A, Clemens F, Piercy D, Gyte G.

Izvor‎: Obstet Gynecol 2007;110(6):1270-8.

Indeks‎: PubMed 18055720

DOI‎: 10.1097/01.AOG.0000288515.48066.99

https://www.ncbi.nlm.nih.gov/pubmed/18055720 (otvara novi prozor)

The use of recombinant activated FVII in postpartum hemorrhage. (otvara novi prozor)

Franchini M, Franchi M, Bergamini V, Montagnana M, Salvagno GL, Targher G, Lippi G.

Izvor‎: Clin Obstet Gynecol 2010;53(1):219-27.

Indeks‎: PubMed 20142658

DOI‎: 10.1097/GRF.0b013e3181cc4378

https://www.ncbi.nlm.nih.gov/pubmed/20142658 (otvara novi prozor)

Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage: single center study. (otvara novi prozor)

Huber AW, Raio L, Alberio L, Ghezzi F, Surbek DV.

Izvor‎: J Perinat Med 2011;40(1):43-9.

Indeks‎: PubMed 22017328

DOI‎: 10.1515/JPM.2011.109

https://www.ncbi.nlm.nih.gov/pubmed/22017328 (otvara novi prozor)

Postpartum hemorrhage: when uterotonics and sutures fail. (otvara novi prozor)

James AH, McLintock C, Lockhart E.

Izvor‎: Am J Hematol 2012;87 Suppl 1:S16-22.

Indeks‎: PubMed 22430921

DOI‎: 10.1002/ajh.23156

https://www.ncbi.nlm.nih.gov/pubmed/22430921 (otvara novi prozor)

Recombinant activated factor VII (rFVIIa/NovoSeven®) in the management of severe postpartum haemorrhage: initial report of a multicentre case series in Japan. (otvara novi prozor)

Kobayashi T, Nakabayashi M, Yoshioka A, Maeda M, Ikenoue T.

Izvor‎: Int J Hematol 2012;95(1):57-63.

Indeks‎: PubMed 22160834

DOI‎: 10.1007/s12185-011-0974-9

https://www.ncbi.nlm.nih.gov/pubmed/22160834 (otvara novi prozor)

Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial. (otvara novi prozor)

Lavigne-Lissalde G, Aya AG, Mercier FJ, Roger-Christoph S, Chauleur C, Morau E, Ducloy-Bouthors AS, Mignon A, Raucoules M, Bongain A, Boehlen F, de Moerloose P, Bouvet S, Fabbro-Peray P, Gris JC.

Izvor‎: J Thromb Haemost 2015;13(4):520-9.

Indeks‎: PubMed 25594352

DOI‎: 10.1111/jth.12844

https://www.ncbi.nlm.nih.gov/pubmed/25594352 (otvara novi prozor)

Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy. (otvara novi prozor)

Lim Y, Loo CC, Chia V, Fun W.

Izvor‎: Int J Gynaecol Obstet 2004;87(2):178-9.

Indeks‎: PubMed 15491576

DOI‎: 10.1016/j.ijgo.2004.08.007

https://www.ncbi.nlm.nih.gov/pubmed/15491576 (otvara novi prozor)

Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. (otvara novi prozor)

Moscardó F, Pérez F, de la Rubia J, Balerdi B, Lorenzo JI, Senent ML, Aznar I, Carceller S, Sanz MA.

Izvor‎: Br J Haematol 2001;114(1):174-6.

Indeks‎: PubMed 11472364

https://www.ncbi.nlm.nih.gov/pubmed/11472364 (otvara novi prozor)

Successful management by recombinant activated factor VII in a case of disseminated intravascular coagulopathy caused by obstetric hemorrhage. (otvara novi prozor)

Nohira T, Osakabe Y, Suda S, Takahashi C, Tanaka A, Ikeda K, Ikeda T, Okabe K.

Izvor‎: J Obstet Gynaecol Res 2008;34(4 Pt 2):623-30.

Indeks‎: PubMed 18840167

https://www.ncbi.nlm.nih.gov/pubmed/18840167 (otvara novi prozor)

Recombinant factor VIIa as last-resort treatment of desperate haemorrhage. (otvara novi prozor)

Palmason R, Vidarsson B, Sigvaldason K, Ingimarsson JP, Gudbjartsson T, Sigurdsson GH, Onundarson PT.

Izvor‎: Acta Anaesthesiol Scand 2012;56(5):636-44.

Indeks‎: PubMed 22489992

DOI‎: 10.1111/j.1399-6576.2012.02688.x

https://www.ncbi.nlm.nih.gov/pubmed/22489992 (otvara novi prozor)

Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation. (otvara novi prozor)

Pepas LP, Arif-Adib M, Kadir RA.

Izvor‎: Obstet Gynecol 2006;108(3 Pt 2):757-61.

Indeks‎: PubMed 17018493

DOI‎: 10.1097/01.AOG.0000197064.44340.d4

https://www.ncbi.nlm.nih.gov/pubmed/17018493 (otvara novi prozor)

Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry. (otvara novi prozor)

Phillips LE, McLintock C, Pollock W, Gatt S, Popham P, Jankelowitz G, Ogle R, Cameron PA; Australian and New Zealand Haemostasis Registry.

Izvor‎: Anesth Analg 2009;109(6):1908-15.

Indeks‎: PubMed 19923520

DOI‎: 10.1213/ANE.0b013e3181c039e6

https://www.ncbi.nlm.nih.gov/pubmed/19923520 (otvara novi prozor)

Recombinant factor VIIa to successfully manage disseminated intravascular coagulation from amniotic fluid embolism. (otvara novi prozor)

Prosper SC, Goudge CS, Lupo VR.

Izvor‎: Obstet Gynecol 2007;109(2 Pt2):524-5.

Indeks‎: PubMed 17267882

DOI‎: 10.1097/01.AOG.0000235711.11817.8c

https://www.ncbi.nlm.nih.gov/pubmed/17267882 (otvara novi prozor)

The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage--an observational study. (otvara novi prozor)

Ahmed S, Harrity C, Johnson S, Varadkar S, McMorrow S, Fanning R, Flynn CM, O'Riordan JM, Byrne BM.

Izvor‎: Transfus Med 2012;22(5):344-9.

Indeks‎: PubMed 22994449

https://www.ncbi.nlm.nih.gov/pubmed/22994449 (otvara novi prozor)

The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. (otvara novi prozor)

Bell SF, Rayment R, Collins PW, Collis RE.

Izvor‎: Int J Obstet Anesth 2010;19(2):218-23.

Indeks‎: PubMed 20194010

DOI‎: 10.1016/j.ijoa.2009.08.004

https://www.ncbi.nlm.nih.gov/pubmed/20194010 (otvara novi prozor)

Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. (otvara novi prozor)

Cortet M, Deneux-Tharaux C, Dupont C, Colin C, Rudigoz RC, Bouvier-Colle MH, Huissoud C.

Izvor‎: Br J Anaesth 2012;108(6):984-9.

Indeks‎: PubMed 22490316

DOI‎: 10.1093/bja/aes096

https://www.ncbi.nlm.nih.gov/pubmed/22490316 (otvara novi prozor)

Association between fibrinogen levels and severity of postpartum hemorrhage in singleton vaginal deliveries at a Japanese perinatal center. (otvara novi prozor)

Shibata Y, Shigemi D, Ito M, Terada K, Nakanishi K, Kato M, Igarashi M, Suzuki S.

Izvor‎: J Nippon Med Sch 2014;81(2):94-6.

Indeks‎: PubMed 24805095

https://www.ncbi.nlm.nih.gov/pubmed/24805095 (otvara novi prozor)

A systematic review: the use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy. (otvara novi prozor)

Trigg DE, Stergiotou I, Peitsidis P, Kadir RA.

Izvor‎: Haemophilia 2012;18(1):25-33.

Indeks‎: PubMed 21624012

DOI‎: 10.1111/j.1365-2516.2011.02573.x

https://www.ncbi.nlm.nih.gov/pubmed/21624012 (otvara novi prozor)

Tisseel for management of traumatic postpartum haemorrhage. (otvara novi prozor)

Dhulkotia JS, Alazzam M, Galimberti A.

Izvor‎: Arch Gynecol Obstet 2009;279(3):437-9.

Indeks‎: PubMed 18985368

DOI‎: 10.1007/s00404-008-0824-z

https://www.ncbi.nlm.nih.gov/pubmed/18985368 (otvara novi prozor)

Use of FloSeal haemostatic gel in massive obstetric haemorrhage: a case report. (otvara novi prozor)

Moriarty KT, Premila S, Bulmer PJ.

Izvor‎: BJOG 2008;115(6):793-5.

Indeks‎: PubMed 18355369

DOI‎: 10.1111/j.1471-0528.2007.01654.x

https://www.ncbi.nlm.nih.gov/pubmed/18355369 (otvara novi prozor)

Topical application of recombinant activated factor VII during cesarean delivery for placenta previa. (otvara novi prozor)

Schjoldager BTBG, Mikkelsen E, Lykke MR, Præst J, Hvas AM, Heslet L, Secher NJ, Salvig JD, Uldbjerg N

Izvor‎: Am J Obstet Gynecol 2017;216(6):608.e1-5.

Indeks‎: PubMed 28219621

DOI‎: 10.1016/j.ajog.2017.02.024

https://www.ncbi.nlm.nih.gov/pubmed/28219621 (otvara novi prozor)

Fibrin sealant for management of complicated obstetric lacerations. (otvara novi prozor)

Whiteside JL, Asif RB, Novello RJ.

Izvor‎: Obstet Gynecol 2010;115(2 Pt 2):403-4.

Indeks‎: PubMed 20093858

DOI‎: 10.1097/AOG.0b013e3181bb1e28

https://www.ncbi.nlm.nih.gov/pubmed/20093858 (otvara novi prozor)

Role of thromboelastography versus coagulation screen as a safety predictor in pre-eclampsia/eclampsia patients undergoing lower-segment caesarean section in regional anaesthesia. (otvara novi prozor)

Ahmad A, Kohli M, Malik A, Kohli M, Bogra J, Abbas H, Gupta R, Kushwaha BB.

Izvor‎: J Obstet Gynaecol India 2016;66(Suppl 1):340-6.

Indeks‎: PubMed 27651627

https://www.ncbi.nlm.nih.gov/pubmed/27651627 (otvara novi prozor)

Assessment of coagulation in the obstetric population using ROTEM® thromboelastometry. (otvara novi prozor)

Armstrong S, Fernando R, Ashpole K, Simons R, Columb M.

Izvor‎: Int J Obstet Anesth 2011;20(4):293-8.

Indeks‎: PubMed 21835606

https://www.ncbi.nlm.nih.gov/pubmed/21835606 (otvara novi prozor)

Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage. (otvara novi prozor)

de Lange NM, Lancé MD, de Groot R, Beckers EA, Henskens YM, Scheepers HC.

Izvor‎: Obstet Gynecol Surv 2012;67(7):426-35.

Indeks‎: PubMed 22926249

DOI‎: 10.1097/OGX.0b013e3182605861

https://www.ncbi.nlm.nih.gov/pubmed/22926249 (otvara novi prozor)

Major obstetric haemorrhage: monitoring with thromboelastography, laboratory analyses or both? (otvara novi prozor)

Karlsson O, Jeppsson A, Hellgren M.

Izvor‎: Int J Obstet Anesth 2014;23(1):10-7.

Indeks‎: PubMed 24342222

https://www.ncbi.nlm.nih.gov/pubmed/24342222 (otvara novi prozor)

Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. (otvara novi prozor)

Levy JH, Welsby I, Goodnough LT.

Izvor‎: Transfusion 2014;54(5):1389-405.

Indeks‎: PubMed 24117955

DOI‎: 10.1111/trf.12431

https://www.ncbi.nlm.nih.gov/pubmed/24117955 (otvara novi prozor)

Coagulopathy and placental abruption: changing management with ROTEM-guided fibrinogen concentrate therapy. (otvara novi prozor)

McNamara H, Mallaiah S, Barclay P, Chevannes C, Bhalla A.

Izvor‎: Int J Obstet Anesth 2015;24(2):174-9.

Indeks‎: PubMed 25659517

https://www.ncbi.nlm.nih.gov/pubmed/25659517 (otvara novi prozor)

Haemostatic monitoring during postpartum haemorrhage and implications for management. (otvara novi prozor)

Solomon C, Collis RE, Collins PW.

Izvor‎: Br J Anaesth 2012;109(6):851-63.

Indeks‎: PubMed 23075633

DOI‎: 10.1093/bja/aes361

https://www.ncbi.nlm.nih.gov/pubmed/23075633 (otvara novi prozor)